To improve bioavailability and patient compliance, oral dispersible drug delivery systems are used mostly because Oral dispersible tablets are the novel dosage form which quickly disintegrates in the mouth (1-3 min) without chewing upon oral administration and without the need of water. As compared to conventional tablets and capsules oral dispersible tablets (ODT) are getting the attention from the last three decades because it has better patient compliances, better solubility, and stability. Oral dispersible tablets have a quality that disintegrates rapidly generally in seconds when put on the tongue because it contains mainly medicinal substances in the solid dosage form. This new ODT technology is enhancing the patient life cycle and making a convenient dosing system for pediatric, geriatric, and psychiatric patients with dysphagia because it directly addresses the pharmaceutical and patient needs. This new technology encourages the academic industry to develop a newer orally disintegrating formulation and technology or evaluation methodology which is suitable for drug candidates for its future prospects. Though considerable research has been done in the formulation development and technologies for ODTs, more intensive investigations are to be carried out in this promising area to result in newer cost-effective technologies and better products. The potential of dosage forms is promising because of the availability of new technologies combined with strong market acceptance and patient compliance.